Bendazac
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | M02AA11 (WHO) S01BC07 (WHO) |
Identifiers | |
| |
CAS Number |
20187-55-7 ![]() |
PubChem (CID) | 2313 |
ChemSpider |
2223 ![]() |
UNII |
G4AG71204O ![]() |
KEGG |
D01594 ![]() |
ChEBI |
CHEBI:31257 ![]() |
ChEMBL |
CHEMBL1089221 ![]() |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.294 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain.
Synthesis
Principal action is inhibition of protein denaturation.

Bendazac synthesis: BE 699226 ; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
See also
References
Pyrazolones / Pyrazolidines | |
---|---|
Salicylates | |
Acetic acid derivatives and related substances | |
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) | |
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. |
Anti-inflammatory preparations, non-steroids |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Capsaicin derivatives | |||||||||||
Other |
This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.